Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements, 59266-59268 [2010-24105]
Download as PDF
59266
Federal Register / Vol. 75, No. 186 / Monday, September 27, 2010 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Responses per
respondent
Average burden
per response
(in hours)
600
1,200
200
400
200
400
100
100
1
1
1
1
1
1
1
1
1.5
6/60
.5
6/60
1.5
6/60
.5
.5
900
120
100
40
300
40
50
50
..........................
..........................
..........................
1,600
Number of
respondents
Type of respondents
Form name
General Resident ..........................
Elected Official ..............................
Industry .........................................
In-depth Interview/phone ..............
Screener .......................................
In-depth Interview/phone ..............
Screener .......................................
In-depth Interview/phone ..............
Screener .......................................
In-depth Interview/phone ..............
In-depth Interview/phone ..............
Total .......................................
.......................................................
Health care provider .....................
Community Leader ........................
Dated: September 21, 2010.
Maryam I. Daneshvar,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
Management, Food and Drug
Administration, 1350 Piccard Dr., PI50–
400B, Rockville, MD 20850, 301–796–
3793.
[FR Doc. 2010–24181 Filed 9–24–10; 8:45 am]
SUPPLEMENTARY INFORMATION:
In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–N–0355]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Current Good
Manufacturing Practice in
Manufacturing, Packaging, Labeling, or
Holding Operations for Dietary
Supplements
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by October 27,
2010.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or emailed to
oira_submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–0606. Also
include the FDA docket number found
in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT:
Denver Presley, Jr., Office of Information
srobinson on DSKHWCL6B1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
17:01 Sep 24, 2010
Jkt 220001
Current Good Manufacturing Practice
in Manufacturing, Packaging, Labeling,
or Holding Operations for Dietary
Supplements (OMB Control Number
0910–0606)—Extension
On October 25, 1994, the Dietary
Supplement Health and Education Act
(DSHEA) (Public Law 103–417) was
signed into law. DSHEA, among other
things, amended the Federal Food,
Drug, and Cosmetic Act (the FD&C Act)
by adding section 402(g) of the FD&C
Act (21 U.S.C. 342(g)). Section 402(g)(2)
of the FD&C Act provides, in part, that
the Secretary of Health and Human
Services (the Secretary) may, by
regulation, prescribe good
manufacturing practices for dietary
supplements. Section 402(g) of the
FD&C Act also stipulates that such
regulations shall be modeled after
current good manufacturing practices
(CGMPs) regulations for food and may
not impose standards for which there
are no current, and generally available,
analytical methodology. Section
402(g)(1) of the FD&C Act states that a
dietary supplement is adulterated if ‘‘it
has been prepared, packed, or held
under conditions that do not meet
current good manufacturing practice
regulations.’’ Under section 701(a) of the
FD&C Act (21 U.S.C. 371), FDA may
issue regulations necessary for the
efficient enforcement of the FD&C Act.
FDA published a final rule on June 25,
2007 (72 FR 34752) (the final rule) that
established, in part 111 (21 CFR part
111), the minimum CGMPs necessary
for activities related to manufacturing,
packaging, labeling, or holding dietary
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
Total burden
hours
supplements to ensure the quality of the
dietary supplement.
Records are an indispensable
component of CGMPs. The records
required by FDA’s regulations in part
111 provide the foundation for the
planning, control, and improvement
processes that constitute a quality
control system. Implementation of these
processes in a manufacturing operation
serves as the backbone to CGMPs. The
records will show what is to be
manufactured; what was, in fact,
manufactured; and whether the controls
that the manufacturer put in place to
control the identity, purity, strength,
and composition and limits on
contaminants and to prevent
adulteration were effective. Further,
records will show whether and what
deviations from control processes
occurred, facilitate evaluation and
corrective action concerning these
deviations (including, where necessary,
whether associated batches of product
should be recalled from the
marketplace), and enable a
manufacturer to assure that the
corrective action was effective. In
addition, by requiring records, FDA will
be able to ensure that industry follows
CGMPs during manufacturing,
packaging, labeling, or holding
operations. The regulations in part 111
establish the minimum manufacturing
practices necessary to ensure that
dietary supplements are manufactured,
packaged, labeled, or held in a manner
that will ensure the quality of the
dietary supplements during
manufacturing, packaging, labeling or
holding operations.
The records requirements of the
regulations include written procedures
and records pertaining to: (1) Personnel;
(2) sanitation; (3) calibration of
instruments and controls; (4)
calibration, inspection, or checks of
automated, mechanical, or electronic
equipment; (5) maintaining, cleaning,
and sanitizing equipment and utensils
and other contact surfaces; (6) water
E:\FR\FM\27SEN1.SGM
27SEN1
Federal Register / Vol. 75, No. 186 / Monday, September 27, 2010 / Notices
used that may become a component of
the dietary supplement; (7) production
and process controls; (8) quality control;
(9) components, packaging, labels and
product received for packaging and
labeling; (10) master manufacturing and
batch production; (11) laboratory
operations; (12) manufacturing
operations; (13) packaging and labeling
operations; (14) holding and distributing
operations; (15) returned dietary
supplements; and (16) product
complaints.
Description of Respondents:
Manufacturers, dietary supplement
manufacturers, packagers and
repackagers, labelers and re-labelers,
holders, distributors, warehousers,
exporters, importers, large businesses,
and small businesses.
The recordkeeping requirements of
the regulations in part 111 are set forth
in each subpart. In table 1 of this
document we list the annual burdens
associated with recordkeeping. In the
table, where the same records are
mentioned in more than one provision
of a subpart, we list the burden under
the provisions corresponding to the
heading in the final rule, ‘‘Under this
subpart, what records must you make
and keep?’’ For some provisions listed in
table 1, we did not estimate the annual
frequency of recordkeeping because
recordkeeping occasions consist of
frequent brief entries of dates,
temperatures, monitoring results, or
documentation that specific actions
were taken. Information might be
recorded a few times a day, week, or
month. When the records burden
involves frequent brief entries, we
entered one as the default for the annual
frequency of recordkeeping. For
example, many of the records listed
under § 111.35 in table 1, such as
§ 111.35(b)(2) (documentation, in
individual equipment logs, of the date
of the use, maintenance, cleaning, and
sanitizing of equipment), involve many
short sporadic entries over the course of
the year, varying across equipment and
plants in the industry. We did not
attempt to estimate the actual number of
recordkeeping occasions for these
provisions, but instead entered an
estimate of the average number of hours
per year. We entered the default value
of 1 as the annual frequency of
recordkeeping for these and similar
provisions. For § 111.35, the entry for
annual frequency is 1 as a default
representing a large number of brief
recordkeeping occasions.
In many rows of table 1 of this
document, we list a burden under a
59267
single provision that covers the written
procedures or records described in
several provisions. For example, the
burden of the batch production records
listed in table 1 under § 111.260
includes the burden for records listed
under § 111.255 because the batch
production records must include those
records.
The annual frequency for batch
production records (and other records
kept on a batch basis in table 1 of this
document) equals the annual number of
batches. The estimated burden for
records kept by batch includes both
records kept for every batch and records
kept for some but not all batches. We
use the annual number of batches as the
frequency for records that will not
necessarily be kept for every batch, such
as test results or material review and
disposition records, because such
records are part of records, if they are
necessary, that will be kept for every
batch.
In the Federal Register of July 14,
2010 (75 FR 40840), FDA published a
60-day notice requesting public
comment on the proposed collection of
information. No comments were
received.
FDA estimates the burden of this
collection of information as follows:
TABLE 1.—ESTIMATED ANNUAL RECORDKEEPING BURDEN1
21 CFR Section
No. of
Recordkeepers
Annual Frequency
per Recordkeeping
Total Annual
Records
Hours per
Record
Total Hours
15,000
4
60,000
1
111.23
15,000
1
15,000
0.2
3,000
111.35
400
1
400
12.5
5,000
111.95
250
1
250
45
11,250
111.140
240
1,163
279,120
1
279,120
111.180
240
1,163
279,120
1
279,120
111.210
240
1
240
111.260
145
1,408
204,160
1
204,160
111.325
120
1
120
15
1,800
111.375
260
1
260
2
520
111.430
50
1
50
12.6
630
111.475
15,000
1
15,000
0.4
6,000
111.535
srobinson on DSKHWCL6B1PROD with NOTICES
111.14
110
4
440
13.5
5,940
111.570
240
600
144,000
0.5
72,000
2.5
Total
1 There
60,000
600
929,140
are no capital costs or operating and maintenance costs associated with this collection of information.
VerDate Mar<15>2010
17:01 Sep 24, 2010
Jkt 220001
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
E:\FR\FM\27SEN1.SGM
27SEN1
srobinson on DSKHWCL6B1PROD with NOTICES
59268
Federal Register / Vol. 75, No. 186 / Monday, September 27, 2010 / Notices
The burden estimates in table 1 of this
document are based on those in the final
rule, which were based on our
institutional experience with other
CGMP requirements and on data
provided by Research Triangle Institute
(RTI) in the ‘‘Survey of Manufacturing
Practices in the Dietary Supplement
Industry’’ cited in that rule.
The estimates in table 1 of the number
of firms affected by each provision of
part 111 are based on the percentage of
manufacturers, packagers, labelers,
holders, distributors, and warehousers
that reported in the survey that they
have not established written standard
operating procedures (SOPs) or do not
maintain records that were later
required by the final rule. Because we
do not have survey results for general
warehouses, we entered the
approximate number of facilities in that
category for those provisions covering
general facilities. For the dietary
supplement industry, the survey
estimated that 1,460 firms would be
covered by the final rule, including
manufacturers, packagers, labelers,
holders, distributors, and warehousers.
The time estimates include the burden
involved in documenting that certain
requirements are performed and in
recordkeeping. We used an estimated
annual batch production of 1,408
batches per year to estimate the burden
of requirements that are related to the
number of batches produced annually,
such as § 111.260, ‘‘What must the batch
production record include?’’ The
estimate of 1,408 batches per year is
near the midpoint of the number of
annual batches reported by survey
firms.
The length of time that CGMP records
must be maintained is set forth in
§ 111.605. Table 1 of this document
reflects the estimated burdens for
written procedures, record maintenance,
periodically reviewing records to
determine if they may be discarded, and
for any associated documentation for
that activity for records that are required
under part 111. We have not included
a separate estimate of burden for those
sections that require maintaining
records in accordance with § 111.605,
but have included those burdens under
specific provisions for keeping records.
For example, § 111.255(a) requires that
the batch production records be
prepared every time a batch is
manufactured, and § 111.255(d) requires
that batch production records be kept in
accordance with § 111.605. The
estimated burdens for both § 111.255(a)
and (d) are included under § 111.260
(what the batch record must include).
VerDate Mar<15>2010
17:01 Sep 24, 2010
Jkt 220001
Dated: September 21, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010–24105 Filed 9–24–10; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–D–0434]
Draft Guidance for Industry: Acidified
Foods; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing the
availability of a draft guidance entitled
‘‘Guidance for Industry: Acidified
Foods.’’ The draft guidance, when
finalized, will complement FDA’s
regulations regarding acidified foods,
including regulations for specific
current good manufacturing practice
(CGMP), establishment registration, and
process filing. The draft guidance is
intended to assist commercial food
processors in determining whether their
food products are subject to these
regulations. The draft guidance also is
intended to assist processors of acidified
foods in ensuring safe manufacturing,
processing, and packing processes and
in employing appropriate quality
control procedures. Under the draft
guidance, processors of non-acidified
foods (e.g., some acid foods or
fermented foods) who are not subject to
the acidified food regulations may
choose to voluntarily register and file
scheduled processes with us using
existing forms (Forms FDA 2541 and
2541a). If such processors voluntarily
submit this information, we plan to
make the results of any FDA evaluation
of the information available to our
investigators, e.g., during inspections of
food facilities and during evaluations of
foods offered for import.
DATES: Although you can comment on
any guidance at any time (see 21 CFR
10.115(g)(5)), to ensure that the agency
considers your comment on this draft
guidance before it begins work on the
final version of the guidance, submit
either electronic or written comments
concerning the draft guidance by
December 27, 2010. Submit either
electronic or written comments
concerning the collection of information
provisions by December 27, 2010.
ADDRESSES: Submit electronic
comments on the draft guidance and the
SUMMARY:
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
proposed collection of information
provisions to https://
www.regulations.gov. Submit written
comments to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. Submit
written requests for single copies of the
draft guidance entitled ‘‘Guidance for
Industry: Acidified Foods’’ to the Office
of Food Safety, Center for Food Safety
and Applied Nutrition (HFS–302), Food
and Drug Administration, 5100 Paint
Branch Pkwy., College Park, MD 20740.
Send two self-addressed adhesive labels
to assist that office in processing your
request, or fax your request to 301–436–
2669. See the SUPPLEMENTARY
INFORMATION section for electronic
access to the draft guidance.
FOR FURTHER INFORMATION CONTACT:
With regard to the draft guidance
document: Michael Mignogna,
Center for Food Safety and Applied
Nutrition (HFS–302), Food and
Drug Administration, 5100 Paint
Branch Parkway, College Park, MD
20740, 301–436–1565.
With regard to the information
collection: Denver Presley, Jr.,
Office of Information Management,
Food and Drug Administration,
1350 Piccard Dr., PI50–400B,
Rockville, MD 20857, 301–796–
3793.
SUPPLEMENTARY INFORMATION:
I. Background
FDA is announcing the availability of
a draft guidance entitled ‘‘Guidance for
Industry: Acidified Foods.’’ The draft
guidance, when finalized, will
complement FDA’s regulations
regarding acidified foods, including
regulations for specific CGMP,
establishment registration, and process
filing. The draft guidance is intended to
assist commercial food processors in
determining whether their food
products are subject to these
regulations. Under the draft guidance,
processors of acid foods and fermented
foods who conclude that such foods
they produce are not also acidified
foods1 may voluntarily register and file
scheduled processes with us using
existing forms (Forms FDA 2541 and
2541a) for acidified foods. Processors of
1 Fermented foods, such as some kinds of
sauerkraut, cucumber pickles, and green olives, are
low-acid foods subjected to the action of acidproducing microorganisms to reduce the pH of the
food. Not all fermented foods meet the definition
of ‘‘acidified foods’’ in 21 CFR 114.3(b). However,
some fermented foods that contain acid are also
acidified foods. We also note that fermented dairy
products, such as yogurt, belong to a separate
category that is not relevant to the fermented foods
that are discussed in this guidance.
E:\FR\FM\27SEN1.SGM
27SEN1
Agencies
[Federal Register Volume 75, Number 186 (Monday, September 27, 2010)]
[Notices]
[Pages 59266-59268]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-24105]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2010-N-0355]
Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Current Good
Manufacturing Practice in Manufacturing, Packaging, Labeling, or
Holding Operations for Dietary Supplements
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995.
DATES: Fax written comments on the collection of information by October
27, 2010.
ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
FAX: 202-395-7285, or emailed to oira_submission@omb.eop.gov. All
comments should be identified with the OMB control number 0910-0606.
Also include the FDA docket number found in brackets in the heading of
this document.
FOR FURTHER INFORMATION CONTACT: Denver Presley, Jr., Office of
Information Management, Food and Drug Administration, 1350 Piccard Dr.,
PI50-400B, Rockville, MD 20850, 301-796-3793.
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.
Current Good Manufacturing Practice in Manufacturing, Packaging,
Labeling, or Holding Operations for Dietary Supplements (OMB Control
Number 0910-0606)--Extension
On October 25, 1994, the Dietary Supplement Health and Education
Act (DSHEA) (Public Law 103-417) was signed into law. DSHEA, among
other things, amended the Federal Food, Drug, and Cosmetic Act (the
FD&C Act) by adding section 402(g) of the FD&C Act (21 U.S.C. 342(g)).
Section 402(g)(2) of the FD&C Act provides, in part, that the Secretary
of Health and Human Services (the Secretary) may, by regulation,
prescribe good manufacturing practices for dietary supplements. Section
402(g) of the FD&C Act also stipulates that such regulations shall be
modeled after current good manufacturing practices (CGMPs) regulations
for food and may not impose standards for which there are no current,
and generally available, analytical methodology. Section 402(g)(1) of
the FD&C Act states that a dietary supplement is adulterated if ``it
has been prepared, packed, or held under conditions that do not meet
current good manufacturing practice regulations.'' Under section 701(a)
of the FD&C Act (21 U.S.C. 371), FDA may issue regulations necessary
for the efficient enforcement of the FD&C Act. FDA published a final
rule on June 25, 2007 (72 FR 34752) (the final rule) that established,
in part 111 (21 CFR part 111), the minimum CGMPs necessary for
activities related to manufacturing, packaging, labeling, or holding
dietary supplements to ensure the quality of the dietary supplement.
Records are an indispensable component of CGMPs. The records
required by FDA's regulations in part 111 provide the foundation for
the planning, control, and improvement processes that constitute a
quality control system. Implementation of these processes in a
manufacturing operation serves as the backbone to CGMPs. The records
will show what is to be manufactured; what was, in fact, manufactured;
and whether the controls that the manufacturer put in place to control
the identity, purity, strength, and composition and limits on
contaminants and to prevent adulteration were effective. Further,
records will show whether and what deviations from control processes
occurred, facilitate evaluation and corrective action concerning these
deviations (including, where necessary, whether associated batches of
product should be recalled from the marketplace), and enable a
manufacturer to assure that the corrective action was effective. In
addition, by requiring records, FDA will be able to ensure that
industry follows CGMPs during manufacturing, packaging, labeling, or
holding operations. The regulations in part 111 establish the minimum
manufacturing practices necessary to ensure that dietary supplements
are manufactured, packaged, labeled, or held in a manner that will
ensure the quality of the dietary supplements during manufacturing,
packaging, labeling or holding operations.
The records requirements of the regulations include written
procedures and records pertaining to: (1) Personnel; (2) sanitation;
(3) calibration of instruments and controls; (4) calibration,
inspection, or checks of automated, mechanical, or electronic
equipment; (5) maintaining, cleaning, and sanitizing equipment and
utensils and other contact surfaces; (6) water
[[Page 59267]]
used that may become a component of the dietary supplement; (7)
production and process controls; (8) quality control; (9) components,
packaging, labels and product received for packaging and labeling; (10)
master manufacturing and batch production; (11) laboratory operations;
(12) manufacturing operations; (13) packaging and labeling operations;
(14) holding and distributing operations; (15) returned dietary
supplements; and (16) product complaints.
Description of Respondents: Manufacturers, dietary supplement
manufacturers, packagers and repackagers, labelers and re-labelers,
holders, distributors, warehousers, exporters, importers, large
businesses, and small businesses.
The recordkeeping requirements of the regulations in part 111 are
set forth in each subpart. In table 1 of this document we list the
annual burdens associated with recordkeeping. In the table, where the
same records are mentioned in more than one provision of a subpart, we
list the burden under the provisions corresponding to the heading in
the final rule, ``Under this subpart, what records must you make and
keep?'' For some provisions listed in table 1, we did not estimate the
annual frequency of recordkeeping because recordkeeping occasions
consist of frequent brief entries of dates, temperatures, monitoring
results, or documentation that specific actions were taken. Information
might be recorded a few times a day, week, or month. When the records
burden involves frequent brief entries, we entered one as the default
for the annual frequency of recordkeeping. For example, many of the
records listed under Sec. 111.35 in table 1, such as Sec.
111.35(b)(2) (documentation, in individual equipment logs, of the date
of the use, maintenance, cleaning, and sanitizing of equipment),
involve many short sporadic entries over the course of the year,
varying across equipment and plants in the industry. We did not attempt
to estimate the actual number of recordkeeping occasions for these
provisions, but instead entered an estimate of the average number of
hours per year. We entered the default value of 1 as the annual
frequency of recordkeeping for these and similar provisions. For Sec.
111.35, the entry for annual frequency is 1 as a default representing a
large number of brief recordkeeping occasions.
In many rows of table 1 of this document, we list a burden under a
single provision that covers the written procedures or records
described in several provisions. For example, the burden of the batch
production records listed in table 1 under Sec. 111.260 includes the
burden for records listed under Sec. 111.255 because the batch
production records must include those records.
The annual frequency for batch production records (and other
records kept on a batch basis in table 1 of this document) equals the
annual number of batches. The estimated burden for records kept by
batch includes both records kept for every batch and records kept for
some but not all batches. We use the annual number of batches as the
frequency for records that will not necessarily be kept for every
batch, such as test results or material review and disposition records,
because such records are part of records, if they are necessary, that
will be kept for every batch.
In the Federal Register of July 14, 2010 (75 FR 40840), FDA
published a 60-day notice requesting public comment on the proposed
collection of information. No comments were received.
FDA estimates the burden of this collection of information as
follows:
Table 1.--Estimated Annual Recordkeeping Burden\1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
No. of Annual Frequency Total Annual
21 CFR Section Recordkeepers per Recordkeeping Records Hours per Record Total Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
111.14 15,000 4 60,000 1 60,000
--------------------------------------------------------------------------------------------------------------------------------------------------------
111.23 15,000 1 15,000 0.2 3,000
--------------------------------------------------------------------------------------------------------------------------------------------------------
111.35 400 1 400 12.5 5,000
--------------------------------------------------------------------------------------------------------------------------------------------------------
111.95 250 1 250 45 11,250
--------------------------------------------------------------------------------------------------------------------------------------------------------
111.140 240 1,163 279,120 1 279,120
--------------------------------------------------------------------------------------------------------------------------------------------------------
111.180 240 1,163 279,120 1 279,120
--------------------------------------------------------------------------------------------------------------------------------------------------------
111.210 240 1 240 2.5 600
--------------------------------------------------------------------------------------------------------------------------------------------------------
111.260 145 1,408 204,160 1 204,160
--------------------------------------------------------------------------------------------------------------------------------------------------------
111.325 120 1 120 15 1,800
--------------------------------------------------------------------------------------------------------------------------------------------------------
111.375 260 1 260 2 520
--------------------------------------------------------------------------------------------------------------------------------------------------------
111.430 50 1 50 12.6 630
--------------------------------------------------------------------------------------------------------------------------------------------------------
111.475 15,000 1 15,000 0.4 6,000
--------------------------------------------------------------------------------------------------------------------------------------------------------
111.535 110 4 440 13.5 5,940
--------------------------------------------------------------------------------------------------------------------------------------------------------
111.570 240 600 144,000 0.5 72,000
--------------------------------------------------------------------------------------------------------------------------------------------------------
Total 929,140
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
[[Page 59268]]
The burden estimates in table 1 of this document are based on those
in the final rule, which were based on our institutional experience
with other CGMP requirements and on data provided by Research Triangle
Institute (RTI) in the ``Survey of Manufacturing Practices in the
Dietary Supplement Industry'' cited in that rule.
The estimates in table 1 of the number of firms affected by each
provision of part 111 are based on the percentage of manufacturers,
packagers, labelers, holders, distributors, and warehousers that
reported in the survey that they have not established written standard
operating procedures (SOPs) or do not maintain records that were later
required by the final rule. Because we do not have survey results for
general warehouses, we entered the approximate number of facilities in
that category for those provisions covering general facilities. For the
dietary supplement industry, the survey estimated that 1,460 firms
would be covered by the final rule, including manufacturers, packagers,
labelers, holders, distributors, and warehousers. The time estimates
include the burden involved in documenting that certain requirements
are performed and in recordkeeping. We used an estimated annual batch
production of 1,408 batches per year to estimate the burden of
requirements that are related to the number of batches produced
annually, such as Sec. 111.260, ``What must the batch production
record include?'' The estimate of 1,408 batches per year is near the
midpoint of the number of annual batches reported by survey firms.
The length of time that CGMP records must be maintained is set
forth in Sec. 111.605. Table 1 of this document reflects the estimated
burdens for written procedures, record maintenance, periodically
reviewing records to determine if they may be discarded, and for any
associated documentation for that activity for records that are
required under part 111. We have not included a separate estimate of
burden for those sections that require maintaining records in
accordance with Sec. 111.605, but have included those burdens under
specific provisions for keeping records. For example, Sec. 111.255(a)
requires that the batch production records be prepared every time a
batch is manufactured, and Sec. 111.255(d) requires that batch
production records be kept in accordance with Sec. 111.605. The
estimated burdens for both Sec. 111.255(a) and (d) are included under
Sec. 111.260 (what the batch record must include).
Dated: September 21, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-24105 Filed 9-24-10; 8:45 am]
BILLING CODE 4160-01-P